# EASSI - Evaluation of the Safety of Self-Administration With Icatibant

> **NCT00997204** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 151 (actual)

## Conditions studied

- Hereditary Angioedema

## Interventions

- **DRUG:** Icatibant

## Key facts

- **NCT ID:** NCT00997204
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-25
- **Primary completion:** 2011-06-22
- **Final completion:** 2011-06-22
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997204, "EASSI - Evaluation of the Safety of Self-Administration With Icatibant". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00997204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*